Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 74,065

Document Document Title
WO/2017/161917A1
System and method of cultivating Cordyceps, specifically provided herein is a system of cultivating Cordyceps comprising: a Helpialus moth trapping device (100); a Hepialus moth eggs screening device (200), wherein the device is connecte...  
WO/2017/162090A1
Provided is a recombinant hansenula-based high dosage hepatitis B vaccine, an HBsAg pure product (stock solution) yield of a recombinant hansenula fermentation broth used for producing the hepatitis B vaccine being 300mg/L – 400mg/L.  
WO/2017/164388A1
The present invention provides information on a mutant xylose isomerase gene and a mutant protein with which it is possible to impart high xylose metabolic capacity to budding yeast. Also provided is a yeast strain having the mutant xylo...  
WO/2017/162092A1
Provided is a hepatitis B treatment vaccine based on an inactivated whole recombinant hansenula cell which expresses HBsAg and HBcAg. An HBsAgVLP and an HBcAgVLP expressed in the recombinant hansenula cell are used as antigens, the amino...  
WO/2017/162669A1
The present invention is directed to the direct application of beneficial or probiotic bacteria to the vaginal niche for maintenance of a healthy vaginal microbiota and to help restore an unbalanced vaginal microbiota. The application is...  
WO/2017/162091A1
A hepatitis B treatment vaccine on the basis of inactivated, fully recombinant Hansenula cells expressing HBsAg. The vaccine is the HBsAg expressed in recombinant Hansenula cells. 108 cells contain 6-10μg HBsAg as an antigen; the vaccin...  
WO/2017/160779A3
The present invention provides a method of detecting one or more Klebsiella species within a sample from a subject, the method comprising: subjecting DNA and/or RNA from the sample to a PCR amplification reaction using primer pairs targe...  
WO/2017/157781A1
The present invention generally relates to a method for degrading malodors with regard to the treatment of hard surfaces, and more particularly relates to the degradation of malodors in the context of dish washing, by contacting said sur...  
WO/2017/160042A1
The present application relates to an L-histidine producing Corynebacterium glutamicum variant and a method for producing L-histidine, using the same.  
WO/2017/159764A1
Provided is a method for manufacturing a chemical by culturing a microorganism using a fermentation raw material comprising cane molasses as a main component, collecting a filtered liquid comprising the chemical in which the microorganis...  
WO/2017/156701A1
Provided is a method for screening and culturing a high-yield and low temperature-tolerant Arthrospira and the low temperature-tolerant Arthrospira obtained by this method, wherein the screening culture method comprises chemical mutagene...  
WO/2017/157773A1
The present invention generally relates to a method for degrading malodors preferably with regard to the treatment of hard and/or soft surfaces, and more particularly relates to the degradation of malodors in dish washing machines, laund...  
WO/2017/157776A1
The present invention generally relates to a method for degrading malodors preferably with regard to the treatment of hard and/or soft surfaces, and more particularly relates to the degradation of malodors in dish washing machines, laund...  
WO/2017/157777A1
The present invention relates to a method for degrading malodors in the in the area of sanitary facilities by using bacterial spores of Bacillus.  
WO/2017/157775A1
The present invention generally relates to a method for degrading malodors with regard to the treatment of hard surfaces, and more particularly relates to the degradation of malodors in the context of dish washing, by contacting said sur...  
WO/2017/157430A1
The present invention relates to the field of microbiology, specifically the field of production of a dairy food product using fermentation and the field of gene transfer by conjugation.  
WO/2017/157780A1
The present invention generally relates to a method for degrading malodors preferably with regard to the treatment of hard and/or soft surfaces, and more particularly relates to the degradation of malodors in dish washing machines, laund...  
WO/2017/159976A1
The present application relates to a putrescine-producing microorganism in which the activity of formate dehydrogenase is activated, and a method for producing putrescine using the same.  
WO/2017/152482A1
Provided are a mycobacteriophage capable of delivering an autonomous luminescent element and a use thereof. The mycobacteriophage contains a gene LuxCDABE needed for the autonomous luminescence in a host bacterium. The autonomous lumines...  
WO/2017/152426A1
Provided is a dwh gene separated from deinococcus radiodurans R1, the nucleotide sequence thereof being shown in SEQ ID NO. 1, and the amino acid sequence of the encoded protein thereof being shown in SEQ ID NO. 2. Further provided is an...  
WO/2017/156356A1
The present invention is a DNA expression vector comprising: a toxP; a mutant toxO that blocks Fe-mediated regulation of gene expression; and a DNA sequence encoding a protein, wherein the toxP and the mutant toxO regulate expression of ...  
WO/2017/152834A1
Provided is phylloporia fontanesiae, which was deposited at the China General Microbiological Culture Collection Center on 27 January 2016, the accession number being: CGMCC No. 11905. Also provided is a use of phylloporia fontanesiae in...  
WO/2017/152137A3
Provided herein are, inter alia, microbial compositions and methods of using the same. The microbial compositions provided include, inter alia, therapeutically effective amounts of Lactobacillus johnsonii, Faecalibacterium prausnitzii, A...  
WO/2017/152137A9
Provided herein are, inter alia, microbial compositions and methods of using the same. The microbial compositions provided include, inter alia, therapeutically effective amounts of Lactobacillus johnsonii, Faecalibacterium prausnitzii, A...  
WO/2017/150720A1
[Problem] To provide an evaluation method for fibrosis and a biomarker for fibrosis evaluation. [Solution] A biomarker for fibrosis evaluation, the biomarker being for detection in biological samples obtained from test animals and includ...  
WO/2017/151684A1
A novel method of growing fungi is disclosed which uses an engineered artificial media and produces high density filamentous fungi biomats that can be harvested with a minimum of processing and from which fungal products such as antibiot...  
WO/2017/148330A1
Disclosed are a method for preparing Crytococcus Neoformans capsular polysaccharide GXM and a GXM antigen immunoassay kit. The preparation method comprises the steps of crude extraction of Crytococcus Neoformans capsular polysaccharide G...  
WO/2017/150849A1
The present invention relates to a novel attenuated Pseudomonas aeruginosa improved in productivity and safety and a vaccine composition for prevention of Pseudomonas aeruginosa infection, comprising the same and, more particularly, to a...  
WO/2017/152137A8
Provided herein are, inter alia, microbial compositions and methods of using the same. The microbial compositions provided include, inter alia, therapeutically effective amounts of Lactobacillus johnsonii, Faecalibacterium prausnitzii, A...  
WO/2017/147130A3
The present invention relates to Bacillus subtilis strains and their use for treatment of shrimp disease such as Early Mortality Syndrome.  
WO/2017/143944A1
A penicillin G acylase mutant constructed by means of gene engineering; when compared with wild-type penicillin G acylase derived from Achromobacter sp.CCM 4824, the synthesis performance of the present penicillin G acylase mutant is gre...  
WO/2017/147130A2
The present invention relates to Bacillus subtilis strains and their use for treatment of shrimp disease such as Early Mortality Syndrome.  
WO/2017/144590A1
The invention relates to a biocatalyst for manufacturing ethanol from amylaceous raw material, said biocatalyst having at least a protease activity, a cellulase activity that is not a β-glucosidase activity, and a β-glucosidase activit...  
WO/2017/143945A1
Provided is a cephalosporin C acylase mutant constructed by means of a point mutation method, a gene for encoding said cephalosporin C acylase mutant, a plasmid comprising said gene, a microorganism for transforming said plasmid, and an ...  
WO/2017/144008A1
Provided is an α amylase variant obtained by the mutation or deletion of at least one amino acid residue in the amino acid sequence of a parent α amylase, and at the same time, same is an α amylase maintaining the capability of the pa...  
WO/2017/139959A1
Disclosed are a high cyclic adenosine monophosphate (cAMP) yielding yeast strain and a construction method therefor. The method comprises constructing Saccharomyces cerevisiae deficient in both protein kinase A catalytic subunit encoding...  
WO/2017/141879A1
In order to provide: a novel pancreatic lipase inhibitor composition derived from a natural product; food, drink, and a pharmaceutical containing the pancreatic lipase inhibitor composition; and a production method for the lipase inhibit...  
WO/2017/142743A1
The present invention concerns one or more bacteria cultures of the genus Bacillus, Lysinibacillus or Pseudomonas, a composition comprising the bacteria cultures, the use of the bacteria cultures for preventing and/or reducing amount of ...  
WO/2017/137547A1
The invention relates to a probiotic composition, which includes at least one lactic acid bacteria strain, preferably Lactobacillus with intestinal tropism, for use intended to promote juvenile livestock growth with stimulation of linear...  
WO/2017/138824A1
A microbial preparation for the mineralization of organic material, in particular cellulose- containing, comprising selected bacterial strains, living or capable of reproduction in the soil, macro- and/or microelements, and also biologic...  
WO/2017/137920A3
The present invention relates to the use of bacterial strains belonging to the species Lactobacillus kefiri in paediatrics to generate and/or maintain the state of homeostasis. The present invention further relates to bacterial strains b...  
WO/2017/135316A1
To provide a fungi of the genus Rhizopus that has a high organic acid productivity. A mutant of the genus Rhizopus that has a reduced pyruvate decarboxylase activity.  
WO/2017/134664A1
A composition of matter comprising an agriculturally acceptable carrier and an endophyte which expresses polynucleotides having the sequences as set forth in SEQ ID NOs: 1-5 or an endophyte which expresses polynucleotides having the sequ...  
WO/2017/131402A1
According to the present invention, a specific Lactobacillus sp. strain, a specific Bifidobacterium sp. strain, a specific Streptococcus sp. strain or a specific Collinsella sp. strain is isolated from human feces, and thus has high safe...  
WO/2017/128781A1
The present invention provides the use of ascorbic acid or pharmaceutically acceptable salts, esters, hydrates or glucoside derivatives thereof in increasing microalgae biomass and also provides a microalgae culture method. Ascorbic acid...  
WO/2017/132578A1
The present invention provides methods and compositions for detecting Mycoplasma exposure in a subject.  
WO/2017/131305A1
The present invention relates to a method for preparing anthocyanin oligomers by using a coenzyme derived from an Aspergillus sp. strain and, more specifically, to a method for preparing anthocyanin oligomers by fermenting anthocyanin mo...  
WO/2017/129515A1
The invention relates to a bacterial strain of species Faecalibacterium prausnitzii deposited at the CNCM under access number CNCM I-4573, for use in the treatment and/or prevention of an inflammatory gastrointestinal illness in an indiv...  
WO/2017/132230A1
Spore forming bacteria and Lactic Acid Bacteria for application in poultry hatcher cabinets to alter the bacterial bloom towards a more beneficial microbiota, positively affecting performance parameters such as mortality, body weight gai...  
WO/2017/128509A1
Provided is a method for in situ protein evolution within an escherichia coli cell. The method may be used for microbial single gene in situ evolution or multiple target gene simultaneous in situ evolution, and is used to increase enzyme...  

Matches 401 - 450 out of 74,065